371 related articles for article (PubMed ID: 21548618)
21. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
22. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.
Dadfar SM; Roemhild K; Drude NI; von Stillfried S; Knüchel R; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2019 Jan; 138():302-325. PubMed ID: 30639256
[TBL] [Abstract][Full Text] [Related]
23. Theranostic magnetic nanoparticles.
Yoo D; Lee JH; Shin TH; Cheon J
Acc Chem Res; 2011 Oct; 44(10):863-74. PubMed ID: 21823593
[TBL] [Abstract][Full Text] [Related]
24. Molecular Imaging of Cancer with Nanoparticle-Based Theranostic Probes.
Ma YY; Jin KT; Wang SB; Wang HJ; Tong XM; Huang DS; Mou XZ
Contrast Media Mol Imaging; 2017; 2017():1026270. PubMed ID: 29097909
[TBL] [Abstract][Full Text] [Related]
25. Lanthanide-Activated Nanoparticles: A Toolbox for Bioimaging, Therapeutics, and Neuromodulation.
Yi Z; Luo Z; Qin X; Chen Q; Liu X
Acc Chem Res; 2020 Nov; 53(11):2692-2704. PubMed ID: 33103883
[TBL] [Abstract][Full Text] [Related]
26. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
27. Magnetic nanoparticles-based diagnostics and theranostics.
Cohen Y; Shoushan SY
Curr Opin Biotechnol; 2013 Aug; 24(4):672-81. PubMed ID: 23415743
[TBL] [Abstract][Full Text] [Related]
28. Recent development of nanoparticles for molecular imaging.
Kim J; Lee N; Hyeon T
Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038377
[TBL] [Abstract][Full Text] [Related]
29. Functionalization of inorganic nanoparticles for bioimaging applications.
Erathodiyil N; Ying JY
Acc Chem Res; 2011 Oct; 44(10):925-35. PubMed ID: 21648430
[TBL] [Abstract][Full Text] [Related]
30. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
31. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
Nguyen KT; Zhao Y
Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
[TBL] [Abstract][Full Text] [Related]
32. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
Santhosh PB; Ulrih NP
Cancer Lett; 2013 Aug; 336(1):8-17. PubMed ID: 23664890
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticles for molecular imaging.
Sheng Y; Liao LD; Thakor NV; Tan MC
J Biomed Nanotechnol; 2014 Oct; 10(10):2641-76. PubMed ID: 25992413
[TBL] [Abstract][Full Text] [Related]
35. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
[TBL] [Abstract][Full Text] [Related]
36. Molecular imaging with theranostic nanoparticles.
Jokerst JV; Gambhir SS
Acc Chem Res; 2011 Oct; 44(10):1050-60. PubMed ID: 21919457
[TBL] [Abstract][Full Text] [Related]
37. Small is Smarter: Nano MRI Contrast Agents - Advantages and Recent Achievements.
Gao Z; Ma T; Zhao E; Docter D; Yang W; Stauber RH; Gao M
Small; 2016 Feb; 12(5):556-76. PubMed ID: 26680328
[TBL] [Abstract][Full Text] [Related]
38. Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles.
Huang J; Zhong X; Wang L; Yang L; Mao H
Theranostics; 2012; 2(1):86-102. PubMed ID: 22272222
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
